Position in UTHR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$257,911
-$23,161 QoQ
Shares Held
476
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#665
of 870 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $1,801,591 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
9,524 | $684,394 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,885 | $301,023 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
476 | $257,911 | |
| 4 | ALKS |
Alkermes plc.
|
4,233 | $221,809 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
11,939 | $191,382 | |
| 6 | HLN |
Haleon plc
|
15,549 | $145,072 |
All Filings in UTHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,911 | 476 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $281,072 | 474 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $219,749 | 451 | Shares | Sole | 2026-01-30 | |
| 2024-12-31 | $220,172 | 624 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $223,610 | 624 | Shares | Sole | 2024-11-01 | |
| No filing history on record for this holder in this stock. | ||||||